HB6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.
Plain-language summary
This bill changes how Medicare and Medicaid decide whether to cover drugs and biologicals used to treat rare diseases. It adjusts the sources of information these programs use when making coverage decisions. The bill affects patients with rare conditions and the drug companies that make treatments for them. Biological drugs are medicines made from living cells or organisms. The bill was recently introduced in Congress and has not yet moved to .
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Upcoming hearings & events
Sponsors
Doris Matsui
Primary SponsorCo-sponsors (26)
Neal Dunn
Mike Thompson
Mike Kelly
Dean Phillips
Melanie Stansbury